Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Emergence of a Thrombospondin Superfamily at the Origin of Metazoans.

Shoemark DK, Ziegler B, Watanabe H, Strompen J, Tucker RP, Özbek S, Adams JC.

Mol Biol Evol. 2019 Mar 13. pii: msz060. doi: 10.1093/molbev/msz060. [Epub ahead of print]

PMID:
30863851
2.

Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.

Smith SA, Sessions RB, Shoemark DK, Williams C, Ebrahimighaei R, McNeill MC, Crump MP, McKay TR, Harris G, Newby AC, Bond M.

J Med Chem. 2019 Jan 31. doi: 10.1021/acs.jmedchem.8b01402. [Epub ahead of print]

PMID:
30640473
3.

The dynamical interplay between a megadalton peptide nanocage and solutes probed by microsecond atomistic MD; implications for design.

Shoemark DK, Avila Ibarra A, Ross JF, Beesley JL, Bray HEV, Mosayebi M, Linden N, Liverpool TB, McIntosh-Smith SN, Woolfson DN, Sessions RB.

Phys Chem Chem Phys. 2018 Dec 19;21(1):137-147. doi: 10.1039/c8cp06282j.

PMID:
30515500
4.

The de novo design of a biocompatible and functional integral membrane protein using minimal sequence complexity.

Lalaurie CJ, Dufour V, Meletiou A, Ratcliffe S, Harland A, Wilson O, Vamasiri C, Shoemark DK, Williams C, Arthur CJ, Sessions RB, Crump MP, Anderson JLR, Curnow P.

Sci Rep. 2018 Oct 1;8(1):14564. doi: 10.1038/s41598-018-31964-8.

5.

The first 142 amino acids of glutamate decarboxylase do not contribute to epitopes recognized by autoantibodies associated with Type 1 diabetes.

Wyatt RC, Brigatti C, Liberati D, Grace SL, Gillard BT, Long AE, Marzinotto I, Shoemark DK, Chandler KA, Achenbach P, Gillespie KM, Piemonti L, Lampasona V, Williams AJK.

Diabet Med. 2018 Jul;35(7):954-963. doi: 10.1111/dme.13628. Epub 2018 Apr 19.

PMID:
29577424
6.

Intraring allostery controls the function and assembly of a hetero-oligomeric class II chaperonin.

Shoemark DK, Sessions RB, Brancaccio A, Bigotti MG.

FASEB J. 2018 Apr;32(4):2223-2234. doi: 10.1096/fj.201701061R. Epub 2018 Jan 5.

7.

ACTN1 variants associated with thrombocytopenia.

Westbury SK, Shoemark DK, Mumford AD.

Platelets. 2017 Sep;28(6):625-627. doi: 10.1080/09537104.2017.1356455. Epub 2017 Aug 31. Review. No abstract available.

PMID:
28856919
8.

Beyond icosahedral symmetry in packings of proteins in spherical shells.

Mosayebi M, Shoemark DK, Fletcher JM, Sessions RB, Linden N, Woolfson DN, Liverpool TB.

Proc Natl Acad Sci U S A. 2017 Aug 22;114(34):9014-9019. doi: 10.1073/pnas.1706825114. Epub 2017 Aug 8.

9.

Decorating Self-Assembled Peptide Cages with Proteins.

Ross JF, Bridges A, Fletcher JM, Shoemark D, Alibhai D, Bray HEV, Beesley JL, Dawson WM, Hodgson LR, Mantell J, Verkade P, Edge CM, Sessions RB, Tew D, Woolfson DN.

ACS Nano. 2017 Aug 22;11(8):7901-7914. doi: 10.1021/acsnano.7b02368. Epub 2017 Jul 11.

PMID:
28686416
10.

16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer's Post-Mortem Brain.

Emery DC, Shoemark DK, Batstone TE, Waterfall CM, Coghill JA, Cerajewska TL, Davies M, West NX, Allen SJ.

Front Aging Neurosci. 2017 Jun 20;9:195. doi: 10.3389/fnagi.2017.00195. eCollection 2017.

11.

Design and nuclear magnetic resonance (NMR) structure determination of the second extracellular immunoglobulin tyrosine kinase A (TrkAIg2) domain construct for binding site elucidation in drug discovery.

Shoemark DK, Williams C, Fahey MS, Watson JJ, Tyler SJ, Scoltock SJ, Ellis RZ, Wickenden E, Burton AJ, Hemmings JL, Bailey CD, Dawbarn D, Jane DE, Willis CL, Sessions RB, Allen SJ, Crump MP.

J Med Chem. 2015 Jan 22;58(2):767-77. doi: 10.1021/jm501307e. Epub 2014 Dec 22.

12.

The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer's disease.

Shoemark DK, Allen SJ.

J Alzheimers Dis. 2015;43(3):725-38. doi: 10.3233/JAD-141170. Review.

PMID:
25125469
13.

Identification of novel small molecule TGF-β antagonists using structure-based drug design.

Wang H, Sessions RB, Prime SS, Shoemark DK, Allen SJ, Hong W, Narayanan S, Paterson IC.

J Comput Aided Mol Des. 2013 Apr;27(4):365-72. doi: 10.1007/s10822-013-9651-9. Epub 2013 Apr 27.

PMID:
23625024
14.

GDNF, NGF and BDNF as therapeutic options for neurodegeneration.

Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK.

Pharmacol Ther. 2013 May;138(2):155-75. doi: 10.1016/j.pharmthera.2013.01.004. Epub 2013 Jan 21. Review.

PMID:
23348013
15.

The core cysteines, (C909) of islet antigen-2 and (C945) of islet antigen-2β, are crucial to autoantibody binding in type 1 diabetes.

Elvers KT, Geoghegan I, Shoemark DK, Lampasona V, Bingley PJ, Williams AJ.

Diabetes. 2013 Jan;62(1):214-22. doi: 10.2337/db11-1590. Epub 2012 Sep 10.

16.

Protein 4.2: a complex linker.

Satchwell TJ, Shoemark DK, Sessions RB, Toye AM.

Blood Cells Mol Dis. 2009 May-Jun;42(3):201-10. doi: 10.1016/j.bcmd.2009.01.005. Epub 2009 Mar 9. Review.

PMID:
19269200
17.

Structure of bacterial glutathione-S-transferase maleyl pyruvate isomerase and implications for mechanism of isomerisation.

Marsh M, Shoemark DK, Jacob A, Robinson C, Cahill B, Zhou NY, Williams PA, Hadfield AT.

J Mol Biol. 2008 Dec 5;384(1):165-77. doi: 10.1016/j.jmb.2008.09.028. Epub 2008 Sep 19.

PMID:
18824004
18.

Enzymatic properties of the lactate dehydrogenase enzyme from Plasmodium falciparum.

Shoemark DK, Cliff MJ, Sessions RB, Clarke AR.

FEBS J. 2007 Jun;274(11):2738-48. Epub 2007 Apr 25.

19.

NGF receptor TrkAd5: therapeutic agent and drug design target.

Dawbarn D, Fahey M, Watson J, Tyler S, Shoemark D, Sessions R, Zhang R, Brady L, Willis C, Allen SJ.

Biochem Soc Trans. 2006 Aug;34(Pt 4):587-90.

PMID:
16856868
20.

Cloning, sequence and expression of the lactate dehydrogenase gene from the human malaria parasite, Plasmodium vivax.

Turgut-Balik D, Akbulut E, Shoemark DK, Celik V, Moreton KM, Sessions RB, Holbrook JJ, Brady RL.

Biotechnol Lett. 2004 Jul;26(13):1051-5.

PMID:
15218378

Supplemental Content

Loading ...
Support Center